ID17088A - Tablet galantamin hidrobromida yang sangat mudah larut - Google Patents
Tablet galantamin hidrobromida yang sangat mudah larutInfo
- Publication number
- ID17088A ID17088A IDP972025A ID972025A ID17088A ID 17088 A ID17088 A ID 17088A ID P972025 A IDP972025 A ID P972025A ID 972025 A ID972025 A ID 972025A ID 17088 A ID17088 A ID 17088A
- Authority
- ID
- Indonesia
- Prior art keywords
- galantamin
- hydrobromides
- tablet
- easy solutions
- solutions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96201676 | 1996-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID17088A true ID17088A (id) | 1997-12-04 |
Family
ID=8224084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDP972025A ID17088A (id) | 1996-06-14 | 1997-06-13 | Tablet galantamin hidrobromida yang sangat mudah larut |
Country Status (33)
Country | Link |
---|---|
US (2) | US6099863A (fr) |
EP (1) | EP0915701B1 (fr) |
JP (1) | JP4172820B2 (fr) |
KR (1) | KR100358676B1 (fr) |
CN (1) | CN1102390C (fr) |
AR (2) | AR008237A1 (fr) |
AT (1) | ATE285777T1 (fr) |
AU (1) | AU726212B2 (fr) |
BG (1) | BG64168B1 (fr) |
BR (1) | BR9709729A (fr) |
CA (1) | CA2257431C (fr) |
CZ (1) | CZ295226B6 (fr) |
DE (1) | DE69732113T2 (fr) |
DK (1) | DK0915701T3 (fr) |
EA (1) | EA001193B1 (fr) |
EE (1) | EE03337B1 (fr) |
ES (1) | ES2235234T3 (fr) |
HK (1) | HK1019703A1 (fr) |
HR (1) | HRP970321B1 (fr) |
ID (1) | ID17088A (fr) |
IL (1) | IL127519A (fr) |
MY (1) | MY121669A (fr) |
NO (1) | NO322892B1 (fr) |
NZ (1) | NZ333280A (fr) |
PL (1) | PL189329B1 (fr) |
PT (1) | PT915701E (fr) |
SI (1) | SI0915701T1 (fr) |
SK (1) | SK284620B6 (fr) |
TR (1) | TR199802592T2 (fr) |
TW (1) | TW506836B (fr) |
UA (1) | UA62930C2 (fr) |
WO (1) | WO1997047304A1 (fr) |
ZA (1) | ZA975281B (fr) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
TW506836B (en) * | 1996-06-14 | 2002-10-21 | Janssen Pharmaceutica Nv | Fast-dissolving galanthamine hydrobromide tablet |
BR9916835A (pt) | 1998-12-24 | 2001-09-25 | Janssen Pharmaceutica Nv | Composição de galantamina de liberação controlada |
US20050063998A1 (en) * | 1999-10-26 | 2005-03-24 | Francois Marc Karel Jozef | Oral solution containing galantamine and a sweetening agent |
US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
EP1284729A4 (fr) * | 2000-04-13 | 2007-12-19 | Mayo Foundation | Agents de reduction de a(beta)42 |
SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US6500454B1 (en) * | 2001-10-04 | 2002-12-31 | Eurand Pharmaceuticals Ltd. | Timed, sustained release systems for propranolol |
DE10235556A1 (de) * | 2002-08-03 | 2004-02-19 | Hf Arzneimittelforschung Gmbh | Medikament und Verfahren zur Verringerung des Alkohol- und/oder Tabakkonsums |
US20040097484A1 (en) * | 2002-11-14 | 2004-05-20 | Marc Cantillion | Once a day galantamine pharmaceutical compositions and methods of use |
DE60313216T2 (de) * | 2002-12-20 | 2008-01-03 | Niconovum Ab | Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
WO2004071431A2 (fr) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Composition et methode de traitement de troubles neurodegeneratifs |
US7521481B2 (en) * | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
DE10338544B4 (de) * | 2003-08-19 | 2017-08-31 | Janssen Pharmaceutica N.V. | Buccale Formulierungen des Galanthamins und deren Anwendungen |
EP1660104B1 (fr) * | 2003-08-26 | 2010-03-10 | Shire Holdings AG | Preparation pharmaceutique contenant des composes de lanthane |
US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
WO2005051489A2 (fr) * | 2003-11-28 | 2005-06-09 | Ranbaxy Laboratories Limited | Formes solides de galanthamine a administration orale et a dissolution rapide |
CA2551946A1 (fr) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Formulations de galantamine |
CA2552114A1 (fr) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Formulations solides d'administration de galantamine |
EP2340813A1 (fr) * | 2003-12-31 | 2011-07-06 | Actavis Group PTC ehf. | Formes galeniques solides a base de galantamine |
WO2006020852A2 (fr) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Composition pharmaceutique et technique de traitement de troubles neurodegeneratifs |
WO2006020850A2 (fr) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Composition pharmaceutique et technique de traitement de troubles neurodegeneratifs |
BRPI0514303A (pt) * | 2004-08-11 | 2008-06-10 | Myriad Genetics Inc | composição farmacêutica e método para tratar distúrbios neurodegenerativos |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
CN101044200A (zh) * | 2004-09-24 | 2007-09-26 | 巴尔的摩马里兰大学 | 治疗有机磷中毒的方法 |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
EP2417969A1 (fr) | 2004-10-21 | 2012-02-15 | Aptalis Pharmatech, Inc. | Compositions pharmaceutiques à saveur masquée avec substances porogènes gastrosolubles |
MX2007005137A (es) * | 2004-11-23 | 2007-06-22 | Warner Lambert Co | Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia. |
US20080145422A1 (en) * | 2005-02-10 | 2008-06-19 | Roxane Laboratories, Inc. | Galantamine tablet formulation |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
GB0516604D0 (en) * | 2005-08-12 | 2005-09-21 | Sandoz Ag | Rapidly dispersing/disintegrating compositions |
US8168219B2 (en) * | 2005-11-30 | 2012-05-01 | Isp Investments Inc. | Synergistic binder composition, method for making same, and tablets of an active and said binder having advantageous hardness and friability |
JP5694645B2 (ja) | 2006-03-16 | 2015-04-01 | ニコノヴァム エービーNiconovum Ab | 改善された嗅ぎたばこ組成物 |
EP2010158B1 (fr) * | 2006-04-26 | 2016-02-17 | Alphapharm Pty Ltd. | Formulations à libération contrôlée qui comprennent une ou plusieurs unités discrètes non enrobées et une matrice à libération retardée |
GB0612540D0 (en) * | 2006-06-23 | 2006-08-02 | Novartis Ag | Galenical formulations of organic compounds |
EP2043613A1 (fr) * | 2006-07-14 | 2009-04-08 | Fmc Corporation | Forme solide |
CN100438917C (zh) * | 2006-07-20 | 2008-12-03 | 山东聊城阿华制药有限公司 | 一种微晶纤维素乳糖的制备方法 |
WO2008062426A2 (fr) * | 2006-08-02 | 2008-05-29 | Emcure Pharmaceuticals Limited | Formulation de dérivés de benzazépine |
EP2420235A1 (fr) | 2006-10-27 | 2012-02-22 | Medivation Neurology, Inc. | Procédés et polythérapies pour traiter la maladie d'Alzheimer |
US20080311162A1 (en) * | 2007-05-16 | 2008-12-18 | Olivia Darmuzey | Solid form |
PE20091156A1 (es) * | 2007-12-17 | 2009-09-03 | Astrazeneca Ab | Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo |
EP2116232B1 (fr) | 2008-05-09 | 2012-02-15 | Ratiopharm GmbH | Médicament à libération contrôlée comprenant de la galanthamine |
CA2782285A1 (fr) | 2009-12-02 | 2011-06-09 | Luigi Mapelli | Microcapsules de fexofenadine et compositions les contenant |
WO2011151359A1 (fr) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Traitement combiné comprenant un inhibiteur de la cholinestérase et un dérivé de thiadiazolidinedione |
JP5656258B2 (ja) * | 2011-03-09 | 2015-01-21 | 塩野義製薬株式会社 | ガランタミンを含有する口腔内崩壊錠剤 |
WO2015022418A1 (fr) | 2013-08-16 | 2015-02-19 | Takeda Gmbh | Traitement d'une déficience cognitive à l'aide d'un inhibiteur de pde4 |
CN106822008A (zh) * | 2017-01-11 | 2017-06-13 | 江苏艾兰得营养品有限公司 | 一种维生素d速溶制剂及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3506276C1 (de) * | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direkttablettiermittel |
US4663318A (en) * | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
US6150354A (en) * | 1987-01-15 | 2000-11-21 | Bonnie Davis | Compounds for the treatment of Alzheimer's disease |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
DK0584185T3 (da) * | 1991-05-14 | 2000-02-07 | Ernir Snorrason | Behandling af træthedssyndrom med cholinesteraseinhibitorer |
TW506836B (en) * | 1996-06-14 | 2002-10-21 | Janssen Pharmaceutica Nv | Fast-dissolving galanthamine hydrobromide tablet |
-
1997
- 1997-05-19 TW TW086106622A patent/TW506836B/zh not_active IP Right Cessation
- 1997-06-06 JP JP50118198A patent/JP4172820B2/ja not_active Expired - Lifetime
- 1997-06-06 DK DK97927159T patent/DK0915701T3/da active
- 1997-06-06 CA CA002257431A patent/CA2257431C/fr not_active Expired - Lifetime
- 1997-06-06 DE DE69732113T patent/DE69732113T2/de not_active Expired - Lifetime
- 1997-06-06 IL IL12751997A patent/IL127519A/en not_active IP Right Cessation
- 1997-06-06 NZ NZ333280A patent/NZ333280A/en not_active IP Right Cessation
- 1997-06-06 EE EE9800429A patent/EE03337B1/xx unknown
- 1997-06-06 BR BR9709729A patent/BR9709729A/pt not_active IP Right Cessation
- 1997-06-06 CZ CZ19984034A patent/CZ295226B6/cs not_active IP Right Cessation
- 1997-06-06 EA EA199900026A patent/EA001193B1/ru not_active IP Right Cessation
- 1997-06-06 UA UA98126372A patent/UA62930C2/uk unknown
- 1997-06-06 WO PCT/EP1997/002986 patent/WO1997047304A1/fr active IP Right Grant
- 1997-06-06 SK SK1696-98A patent/SK284620B6/sk not_active IP Right Cessation
- 1997-06-06 AT AT97927159T patent/ATE285777T1/de active
- 1997-06-06 PT PT97927159T patent/PT915701E/pt unknown
- 1997-06-06 ES ES97927159T patent/ES2235234T3/es not_active Expired - Lifetime
- 1997-06-06 AU AU31743/97A patent/AU726212B2/en not_active Expired
- 1997-06-06 US US09/202,187 patent/US6099863A/en not_active Expired - Lifetime
- 1997-06-06 SI SI9730690T patent/SI0915701T1/xx unknown
- 1997-06-06 KR KR10-1998-0709401A patent/KR100358676B1/ko not_active IP Right Cessation
- 1997-06-06 PL PL97330431A patent/PL189329B1/pl unknown
- 1997-06-06 EP EP97927159A patent/EP0915701B1/fr not_active Expired - Lifetime
- 1997-06-06 TR TR1998/02592T patent/TR199802592T2/xx unknown
- 1997-06-06 CN CN97195512A patent/CN1102390C/zh not_active Expired - Lifetime
- 1997-06-11 HR HR970321A patent/HRP970321B1/xx not_active IP Right Cessation
- 1997-06-12 MY MYPI97002621A patent/MY121669A/en unknown
- 1997-06-13 AR ARP970102615A patent/AR008237A1/es active IP Right Grant
- 1997-06-13 ZA ZA975281A patent/ZA975281B/xx unknown
- 1997-06-13 ID IDP972025A patent/ID17088A/id unknown
-
1998
- 1998-12-04 BG BG102991A patent/BG64168B1/bg unknown
- 1998-12-11 NO NO19985815A patent/NO322892B1/no not_active IP Right Cessation
-
1999
- 1999-07-10 HK HK99102948A patent/HK1019703A1/xx not_active IP Right Cessation
-
2000
- 2000-06-01 US US09/585,122 patent/US6358527B1/en not_active Expired - Lifetime
-
2008
- 2008-11-25 AR ARP080105111A patent/AR070670A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID17088A (id) | Tablet galantamin hidrobromida yang sangat mudah larut | |
NO985499D0 (no) | Likestr°mstransformator/reaktor | |
ID26334A (id) | Morfolinol yang aktif secara farmasi | |
ID28110A (id) | Surfaktan alkilbenzenasulfonat yang disempurnakan | |
NO975894L (no) | Foringsr°rpakning | |
DE69716101T2 (de) | Wasserundurchlässige gesichtsmaske | |
NO984316D0 (no) | Skjµreverkt°y | |
DE69739919D1 (de) | Polyelektrolyt | |
ID29629A (id) | Tablet yang lapas-segera | |
DK0966287T3 (da) | Oxacarbazepinfilmovertrukne tabletter | |
NO303590B1 (no) | L°pehjul | |
DK0812808T3 (da) | Vandblødgøringstabletter | |
NO990552D0 (no) | Innrettingsverkt°y | |
ID23735A (id) | Tablet trovafloksasin mesilat | |
ID21770A (id) | Plester yang mengandung felbinak | |
NO973953D0 (no) | Sprinklersystem | |
NO305650B1 (no) | L°ftejekk | |
NO985395D0 (no) | L°fteanordning | |
NO992852D0 (no) | Basisstr°mningsenhet | |
ATA198296A (de) | Peltonrad - vorspannung | |
NO964898D0 (no) | Elektrokjemisk anlegg | |
ID17786A (id) | Sel fotoelektrokima | |
DE59804973D1 (de) | Rundlauf-Tablettenpresse | |
KR980000948U (ko) | 블록 놀이 기구 | |
DE69624511D1 (de) | Umkehrbares pumpe-turbine system |